Hanhui Pharma has multiple products for the treatment of hematological neoplasms and solid tumors. For hematological neoplasms, diseases targeted by the company's products include leukemia, lymphoma, myelodysplastic syndrome (MDS), etc., which enables the full course management of acute myeloid leukemia (AML). Products targeting solid tumors include breast cancer, lymphoma, bone tumor, ovarian cancer, bladder cancer, etc.
Hanhui Pharma has multiple products for the treatment of hematological neoplasms and solid tumors. For hematological neoplasms, diseases targeted by the company's products include leukemia, lymphoma, myelodysplastic syndrome (MDS), etc., which enables the full course management of acute myeloid leukemia (AML). Products targeting solid tumors include breast cancer, lymphoma, bone tumor, ovarian cancer, bladder cancer, etc.
